Sii

SII To Begin Production Of Sputnik V Vaccines In Sep, Targets 300 Million Doses Per Year

Big Blow To Serum Institute As Govt Panel Denies To Conduct Trials Of Covovax On Children Aged 2-17 Yrs

Coronavirus HIGHLIGHTS: Confident Of Getting EMA's Approval In A month For Covishield, Says SII Chief Adar Poonawalla

Vaccination Passport: Adar Poonawala Assures Resolution Of Entry In EU With Covishield Jabs

Covid Vaccine Prices To Be Revised, Centre In Talks With Serum Institute & Bharat Biotech: Sources

Covishield Elicits Better Antibody Response Than Covaxin: Study

Biological E’s Corbevax At Rs 250/Dose May Be Cheapest Covid-19 Vaccine In India

Serum Institute Gets DCGI's Nod To Manufacture Russia's Covid Vaccine Sputnik V In India

Adar Poonawalla Thanks US & India For Key Policy Change, Expresses Hope For Boosting Vaccine Production

Covishield Producer SII Seeks DCGI Approval To Manufacture Sputnik V Covid Vaccine

'Rules Should Be Same For All': SII Seeks Indemnity Protection After Moderna & Pfizer

Lucknow Man Files Complaint Against Adar Poonawalla, Alleges No Antibodies Developed After Covishield Dose